Natera is a biotechnology company that specializes in genetic testing to improve patient outcomes through precision medicine and innovative diagnostic solutions.
View Article For:
๐งฌ Natera specializes in genetic testing and diagnostics for reproductive health and oncology.
๐ The company has a global presence, offering its services in multiple countries around the world.
๐ Natera went public in 2015, trading on the NASDAQ under the ticker symbol 'NTRA'.
โ๏ธ Their technology combines advanced algorithms with genetic sequencing to provide accurate results.
๐ถ Natera's tests help expectant parents understand the genetic health of their unborn children.
๐ Natera conducts extensive research and has published numerous studies to validate their testing methods.
๐ผ The company partners with healthcare providers and payers to improve patient care and accessibility to genetic testing.
๐ฉบ Natera offers tests that can detect various genetic conditions, including chromosomal abnormalities and cancers.
๐ฌ Their flagship product is Panorama, a non-invasive prenatal test that screens for fetal chromosomal conditions.
๐ Natera aims to improve the clinical utility of genetic testing and expand its offerings in various medical fields.